{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T16:25:24Z","timestamp":1789057524554,"version":"build-2803163510"},"reference-count":63,"publisher":"Elsevier BV","issue":"5-6","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,14]],"date-time":"2024-05-14T00:00:00Z","timestamp":1715644800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Microbes and Infection"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.micinf.2024.105342","type":"journal-article","created":{"date-parts":[[2024,4,26]],"date-time":"2024-04-26T15:34:28Z","timestamp":1714145668000},"page":"105342","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Engineering Mycoplasma pneumoniae to bypass the association with Guillain-Barr\u00e9 syndrome"],"prefix":"10.1016","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3275-8524","authenticated-orcid":false,"given":"Alicia","family":"Broto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5263-3702","authenticated-orcid":false,"given":"Carlos","family":"Pi\u00f1ero-Lambea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1746-6865","authenticated-orcid":false,"given":"Carolina","family":"Segura-Morales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne P.","family":"Tio-Gillen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9484-261X","authenticated-orcid":false,"given":"Wendy W.J.","family":"Unger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4452-9235","authenticated-orcid":false,"given":"Raul","family":"Burgos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rocco","family":"Mazzolini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1542-5912","authenticated-orcid":false,"given":"Samuel","family":"Miravet-Verde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart C.","family":"Jacobs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josefina","family":"Casas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9563-4860","authenticated-orcid":false,"given":"Ruth","family":"Huizinga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Lluch-Senar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Serrano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.micinf.2024.105342_bib1","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1038\/s41467-020-15508-1","article-title":"Developing a new class of engineered live bacterial therapeutics to treat human diseases","volume":"11","author":"Charbonneau","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.micinf.2024.105342_bib2","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.trecan.2020.11.004","article-title":"Tweak to treat: Reprograming bacteria for cancer treatment","volume":"7","author":"Sieow","year":"2021","journal-title":"Trends Canc."},{"key":"10.1016\/j.micinf.2024.105342_bib3","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.copbio.2015.05.004","article-title":"Engineered bacteria as therapeutic agents","volume":"35","author":"Pi\u00f1ero-Lambea","year":"2015","journal-title":"Curr Opin Biotechnol"},{"key":"10.1016\/j.micinf.2024.105342_bib4","doi-asserted-by":"crossref","DOI":"10.15252\/msb.202010145","article-title":"Engineering a genome-reduced bacterium to eliminate Staphylococcus aureus biofilms in\u00a0vivo","volume":"17","author":"Garrido","year":"2021","journal-title":"Mol Syst Biol"},{"key":"10.1016\/j.micinf.2024.105342_bib5","doi-asserted-by":"crossref","DOI":"10.15252\/msb.202211037","article-title":"Bacterial expression of a designed single-chain <scp>IL<\/scp> -10 prevents severe lung inflammation","author":"Montero-Blay","year":"2023","journal-title":"Mol Syst Biol"},{"key":"10.1016\/j.micinf.2024.105342_bib6","doi-asserted-by":"crossref","DOI":"10.1038\/s41587-022-01584-9","article-title":"Engineered live bacteria suppress Pseudomonas aeruginosa infection in mouse lung and dissolve endotracheal-tube biofilms","author":"Mazzolini","year":"2023","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.micinf.2024.105342_bib7","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3389\/fmicb.2016.00023","article-title":"Classification of extrapulmonary manifestations due to mycoplasma pneumoniae infection on the basis of possible pathogenesis","volume":"7","author":"Narita","year":"2016","journal-title":"Front Microbiol"},{"key":"10.1016\/j.micinf.2024.105342_bib8","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/S0140-6736(69)90426-7","article-title":"Mycoplasma penumoniae as a determinant of the guillain-barr\u00e9 syndrome","volume":"294","author":"Steele","year":"1969","journal-title":"Lancet"},{"key":"10.1016\/j.micinf.2024.105342_bib9","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0165-5728(02)00209-6","article-title":"Cross-reactive anti-galactocerebroside antibodies and Mycoplasma pneumoniae infections in Guillain\u2013Barr\u00e9 syndrome","volume":"130","author":"Ang","year":"2002","journal-title":"J\u00a0Neuroimmunol"},{"key":"10.1016\/j.micinf.2024.105342_bib10","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S0140-6736(16)00339-1","article-title":"Guillain-Barr\u00e9 syndrome","volume":"388","author":"Willison","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.micinf.2024.105342_bib11","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1159\/000324710","article-title":"Population incidence of Guillain-Barr\u00e9 syndrome: a systematic review and meta-analysis","volume":"36","author":"Sejvar","year":"2011","journal-title":"Neuroepidemiology"},{"key":"10.1016\/j.micinf.2024.105342_bib12","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1212\/WNL.51.4.1110","article-title":"The spectrum of antecedent infections in Guillain-Barr\u00e9 syndrome","volume":"51","author":"Jacobs","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.micinf.2024.105342_bib13","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jneuroim.2017.11.011","article-title":"Intrathecal antibody responses to GalC in Guillain-Barr\u00e9 syndrome triggered by Mycoplasma pneumoniae","volume":"314","author":"Meyer Sauteur","year":"2018","journal-title":"J\u00a0Neuroimmunol"},{"key":"10.1016\/j.micinf.2024.105342_bib14","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1002\/mus.20762","article-title":"Ganglioside mimicry and peripheral nerve disease","volume":"35","author":"Yuki","year":"2007","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.micinf.2024.105342_bib15","doi-asserted-by":"crossref","first-page":"6338","DOI":"10.1111\/febs.12559","article-title":"Glycosphingolipids: synthesis and functions","volume":"280","author":"D'Angelo","year":"2013","journal-title":"FEBS J"},{"key":"10.1016\/j.micinf.2024.105342_bib16","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1016\/j.bbamem.2006.04.020","article-title":"Biophysics of sphingolipids II. Glycosphingolipids: an assortment of multiple structural information transducers at the membrane surface","volume":"1758","author":"Maggio","year":"2006","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.micinf.2024.105342_bib17","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/S0166-2236(97)01178-8","article-title":"New perspectives on the function of myelin galactolipids","volume":"21","author":"Coet","year":"1998","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.micinf.2024.105342_bib18","doi-asserted-by":"crossref","first-page":"11404","DOI":"10.1073\/pnas.0402391101","article-title":"Carbohydrate mimicry between human ganglioside GM1 and Campylobacter jejuni lipooligosaccharide causes Guillain-Barr\u00e9 syndrome","volume":"101","author":"Yuki","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.micinf.2024.105342_bib19","doi-asserted-by":"crossref","first-page":"459","DOI":"10.3855\/jidc.1508","article-title":"The presence of Mycoplasma pneumoniae infection and GM1 ganglioside antibodies in Guillain-Barr\u00e9 syndrome","volume":"5","author":"Sharma","year":"2011","journal-title":"J\u00a0Inf Develop Countr"},{"key":"10.1016\/j.micinf.2024.105342_bib20","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/S0165-5728(97)00166-5","article-title":"Antibodies to gangliosides and galactocerebroside in patients with Guillain-Barr\u00e9 syndrome with preceding Campylobacter jejuni and other identified infections","volume":"81","author":"Hao","year":"1998","journal-title":"J\u00a0Neuroimmunol"},{"key":"10.1016\/j.micinf.2024.105342_bib21","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1212\/WNL.57.4.736","article-title":"Anti-Gal-C antibodies in GBS subsequent to mycoplasma infection: evidence of molecular mimicry","volume":"57","author":"Kusunoki","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.micinf.2024.105342_bib22","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1002\/ana.24755","article-title":"Mycoplasma pneumoniae triggering the Guillain-Barr\u00e9 syndrome: a case-control study","volume":"80","author":"Meyer Sauteur","year":"2016","journal-title":"Ann Neurol"},{"key":"10.1016\/j.micinf.2024.105342_bib23","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/jns.12243","article-title":"Antibody responses to GalC in severe and complicated childhood Guillain-Barr\u00e9 syndrome","volume":"23","author":"Meyer Sauteur","year":"2018","journal-title":"J\u00a0Peripher Nerv Syst : JPNS"},{"key":"10.1016\/j.micinf.2024.105342_bib24","first-page":"467","article-title":"Characterization of the neurological diseases associated with Mycoplasma pneumoniae infection and anti-glycolipid antibodies","volume":"264","author":"Kuwahara","year":"2017","journal-title":"J\u00a0Neurol"},{"key":"10.1016\/j.micinf.2024.105342_bib25","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1146\/annurev.mi.23.100169.001533","article-title":"Structure and function in mycoplasma","volume":"23","author":"Razin","year":"1969","journal-title":"Annu Rev Microbiol"},{"key":"10.1016\/j.micinf.2024.105342_bib26","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/icb.1969.19","article-title":"Immunochemical analysis of Mycoplasma pneumoniae: 3. Separation and chemical identification of serologically active lipids","volume":"47","author":"Plackett","year":"1969","journal-title":"Aust J Exp Biol Med Sci"},{"key":"10.1016\/j.micinf.2024.105342_bib27","doi-asserted-by":"crossref","first-page":"4420","DOI":"10.1093\/nar\/24.22.4420","article-title":"Complete sequence analysis of the genome of the bacterium Mycoplasma pneumoniae","volume":"24","author":"Himmelreich","year":"1996","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.micinf.2024.105342_bib28","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1126\/science.1177263","article-title":"Impact of genome reduction on bacterial metabolism and its regulation","volume":"326","author":"Yus","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.micinf.2024.105342_bib29","series-title":"Food and drug administration","article-title":"Early clinical trials with live biotherapeutic products: chemistry, manufacturing, and control information U.S. Department of Health and Human Services","year":"2016"},{"key":"10.1016\/j.micinf.2024.105342_bib30","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkac836","article-title":"SURE editing: combining oligo-recombineering and programmable insertion\/deletion of selection markers to efficiently edit the Mycoplasma pneumoniae genome","author":"Pi\u00f1ero-Lambea","year":"2022","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.micinf.2024.105342_bib31","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1093\/dnares\/dsz012","article-title":"SynMyco transposon: engineering transposon vectors for efficient transformation of minimal genomes","volume":"26","author":"Montero-Blay","year":"2019","journal-title":"DNA Res"},{"key":"10.1016\/j.micinf.2024.105342_bib32","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1099\/mic.0.28287-0","article-title":"Comparative analysis of antibiotic resistance gene markers in Mycoplasma genitalium: application to studies of the minimal gene complement","volume":"152","author":"Pich","year":"2006","journal-title":"Microbiology"},{"key":"10.1016\/j.micinf.2024.105342_bib33","doi-asserted-by":"crossref","DOI":"10.1021\/acssynbio.0c00022","article-title":"Mycoplasma pneumoniae genome editing based on oligo recombineering and Cas9-mediated counterselection","author":"Pi\u00f1ero Lambea","year":"2020","journal-title":"ACS Synth Biol"},{"key":"10.1016\/j.micinf.2024.105342_bib34","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.mimet.2005.02.011","article-title":"An improved arbitrary primed PCR method for rapid characterization of transposon insertion sites","volume":"63","author":"Das","year":"2005","journal-title":"J\u00a0Microbiol Methods"},{"key":"10.1016\/j.micinf.2024.105342_bib35","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/nmeth.1318","article-title":"Enzymatic assembly of DNA molecules up to several hundred kilobases","volume":"6","author":"Gibson","year":"2009","journal-title":"Nat Methods"},{"key":"10.1016\/j.micinf.2024.105342_bib36","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0189209","article-title":"QCloud: a cloud-based quality control system for mass spectrometry-based proteomics laboratories","volume":"13","author":"Chiva","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.micinf.2024.105342_bib37","doi-asserted-by":"crossref","first-page":"3551","DOI":"10.1002\/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2","article-title":"Probability-based protein identification by searching sequence databases using mass spectrometry data","volume":"20","author":"Perkins","year":"1999","journal-title":"Electrophoresis"},{"key":"10.1016\/j.micinf.2024.105342_bib38","first-page":"339","article-title":"Efficient quantitative comparisons of plasma proteomes using label-free analysis with MaxQuant","volume":"vol. 1619","author":"Beer","year":"2017"},{"key":"10.1016\/j.micinf.2024.105342_bib39","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkab1038","article-title":"The PRIDE database resources in 2022: a hub for mass spectrometry-based proteomics evidences","volume":"50","author":"Perez-Riverol","year":"2022","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.micinf.2024.105342_bib40","article-title":"Plasmalogen enrichment in exosomes secreted by a nematode parasite versus those derived from its mouse host: implications for exosome stability and biology","volume":"5","author":"Simbari","year":"2016","journal-title":"J\u00a0Extracell Vesicles"},{"key":"10.1016\/j.micinf.2024.105342_bib41","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20112835","article-title":"Regulation of serum sphingolipids in andean children born and living at high altitude (3775 m)","volume":"20","author":"Barbacini","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.micinf.2024.105342_bib42","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1021\/acs.analchem.5b04227","article-title":"Tandem mass spectrometry multiplex analysis of glucosylceramide and galactosylceramide isoforms in brain tissues at different stages of Parkinson disease","volume":"88","author":"Boutin","year":"2016","journal-title":"Anal Chem"},{"key":"10.1016\/j.micinf.2024.105342_bib43","doi-asserted-by":"crossref","DOI":"10.1128\/IAI.00663-18","article-title":"Antibodies to protein but not glycolipid structures are important for host defense against mycoplasma pneumoniae","volume":"87","author":"Meyer Sauteur","year":"2019","journal-title":"Infect Immun"},{"key":"10.1016\/j.micinf.2024.105342_bib44","doi-asserted-by":"crossref","first-page":"780","DOI":"10.15252\/msb.20145558","article-title":"Defining a minimal cell: essentiality of small ORFs and ncRNAs in a genome-reduced bacterium","volume":"11","author":"Lluch-Senar","year":"2015","journal-title":"Mol Syst Biol"},{"key":"10.1016\/j.micinf.2024.105342_bib45","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkaa679","article-title":"FASTQINS and ANUBIS: two bioinformatic tools to explore facts and artifacts in transposon sequencing and essentiality studies","volume":"48","author":"Miravet-Verde","year":"2020","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.micinf.2024.105342_bib46","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/0005-2736(80)90042-5","article-title":"Phospholipid and cholesterol uptake by mycoplasma cells and membranes","volume":"598","author":"Razin","year":"1980","journal-title":"Biochim Biophys Acta Biomembr"},{"key":"10.1016\/j.micinf.2024.105342_bib47","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1111\/j.1365-2958.2007.05865.x","article-title":"A\u00a0processive lipid glycosyltransferase in the small human pathogen Mycoplasma pneumoniae: involvement in host immune response","volume":"65","author":"Ros\u00e9n Klement","year":"2007","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.micinf.2024.105342_bib48","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1128\/MMBR.62.4.1094-1156.1998","article-title":"Molecular biology and pathogenicity of mycoplasmas","volume":"62","author":"Razin","year":"1998","journal-title":"Microbiol Mol Biol Rev : MMBR (Microbiol Mol Biol Rev)"},{"key":"10.1016\/j.micinf.2024.105342_bib49","doi-asserted-by":"crossref","first-page":"35367","DOI":"10.1074\/jbc.M110.214148","article-title":"Expression and characterization of a mycoplasma genitalium glycosyltransferase in membrane glycolipid biosynthesis","volume":"286","author":"Andr\u00e9s","year":"2011","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.micinf.2024.105342_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.107722","article-title":"Inferring active metabolic pathways from proteomics and essentiality data","volume":"31","author":"Montero-Blay","year":"2020","journal-title":"Cell Rep"},{"key":"10.1016\/j.micinf.2024.105342_bib51","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1046\/j.1365-2958.1998.00930.x","article-title":"A\u00a0UDP glucosyltransferase from Bacillus subtilis successively transfers up to four glucose residues to 1,2-diacylglycerol: expression of ypfP in Escherichia coli and structural analysis of its reaction products","volume":"29","author":"Jorasch","year":"1998","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.micinf.2024.105342_bib52","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-50020-7","article-title":"Mixing brain cerebrosides with brain ceramides, cholesterol and phospholipids","volume":"9","author":"Gonz\u00e1lez-Ram\u00edrez","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.micinf.2024.105342_bib53","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.fct.2018.12.022","article-title":"Cellular toxicity of dietary trans fatty acids and its correlation with ceramide and diglyceride accumulation","volume":"124","author":"Sarnyai","year":"2019","journal-title":"Food Chem Toxicol"},{"key":"10.1016\/j.micinf.2024.105342_bib54","doi-asserted-by":"crossref","first-page":"19611","DOI":"10.1021\/jacs.0c08583","article-title":"Chemoenzymatic synthesis of Campylobacter jejuni lipo-oligosaccharide core domains to examine Guillain-Barr\u00e9 syndrome serum antibody Specificities","volume":"142","author":"Li","year":"2020","journal-title":"J\u00a0Am Chem Soc"},{"key":"10.1016\/j.micinf.2024.105342_bib55","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1016\/j.jaip.2023.04.002","article-title":"Intravenous immunoglobulin: mechanism of action in autoimmune and inflammatory conditions","volume":"11","author":"Bayry","year":"2023","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.micinf.2024.105342_bib56","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.jneuroim.2007.06.017","article-title":"Anti-galactocerebroside testing in Mycoplasma pneumoniae-associated encephalitis","volume":"189","author":"Christie","year":"2007","journal-title":"J\u00a0Neuroimmunol"},{"key":"10.1016\/j.micinf.2024.105342_bib57","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003983","article-title":"Antibody responses to mycoplasma pneumoniae: role in pathogenesis and diagnosis of encephalitis?","volume":"10","author":"Meyer Sauteur","year":"2014","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.micinf.2024.105342_bib58","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.it.2022.02.003","article-title":"Guillain-Barr\u00e9 syndrome: expanding the concept of molecular mimicry","volume":"43","author":"Laman","year":"2022","journal-title":"Trends Immunol"},{"key":"10.1016\/j.micinf.2024.105342_bib59","doi-asserted-by":"crossref","first-page":"S48","DOI":"10.1016\/S0264-410X(03)00200-7","article-title":"Innate immune responses support adaptive immunity: NKT cells induce B cell activation","volume":"21","author":"Galli","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.micinf.2024.105342_bib60","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1038\/ni1380","article-title":"Natural killer T cells recognize diacylglycerol antigens from pathogenic bacteria","volume":"7","author":"Kinjo","year":"2006","journal-title":"Nat Immunol"},{"key":"10.1016\/j.micinf.2024.105342_bib61","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1021\/jm00012a018","article-title":"Structure-activity relationship of alpha-galactosylceramides against B16-bearing mice","volume":"38","author":"Morita","year":"1995","journal-title":"J\u00a0Med Chem"},{"key":"10.1016\/j.micinf.2024.105342_bib62","doi-asserted-by":"crossref","first-page":"3625","DOI":"10.4049\/jimmunol.176.6.3625","article-title":"Conserved and heterogeneous lipid antigen specificities of CD1d-restricted NKT cell receptors","volume":"176","author":"Brigl","year":"2006","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.micinf.2024.105342_bib63","doi-asserted-by":"crossref","first-page":"3693","DOI":"10.4049\/jimmunol.173.6.3693","article-title":"Quantitative and qualitative differences in the in\u00a0vivo response of NKT cells to distinct alpha- and beta-anomeric glycolipids","volume":"173","author":"Parekh","year":"2004","journal-title":"J\u00a0Immunol"}],"container-title":["Microbes and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1286457924000728?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1286457924000728?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,4]],"date-time":"2024-07-04T00:50:45Z","timestamp":1720054245000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1286457924000728"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":63,"journal-issue":{"issue":"5-6","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["S1286457924000728"],"URL":"https:\/\/doi.org\/10.1016\/j.micinf.2024.105342","relation":{},"ISSN":["1286-4579"],"issn-type":[{"value":"1286-4579","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Engineering Mycoplasma pneumoniae to bypass the association with Guillain-Barr\u00e9 syndrome","name":"articletitle","label":"Article Title"},{"value":"Microbes and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.micinf.2024.105342","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Masson SAS on behalf of Institut Pasteur.","name":"copyright","label":"Copyright"}],"article-number":"105342"}}